• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Fos 在骨微环境中破骨细胞前体的 RANK 表达上调中发挥重要作用。

Fos plays an essential role in the upregulation of RANK expression in osteoclast precursors within the bone microenvironment.

机构信息

Institute for Oral Science, Matsumoto Dental University, Nagano 399-0781, Japan.

出版信息

J Cell Sci. 2012 Jun 15;125(Pt 12):2910-7. doi: 10.1242/jcs.099986. Epub 2012 Mar 27.

DOI:10.1242/jcs.099986
PMID:22454522
Abstract

Fos plays essential roles in the osteoclastic differentiation of precursor cells generated by colony-stimulating factor 1 (CSF-1) and receptor activator of NF-κB ligand (RANKL; also known as tumor necrosis factor ligand superfamily member 11, Tnsf11). RANKL-deficient (RANKL(-/-)) mice and Fos(-/-) mice exhibit osteopetrosis due to an osteoclast deficiency. We previously reported that RANK-positive osteoclast precursors are present in bone of RANKL(-/-) mice but not Fos(-/-) mice. Here we report the role of Fos in RANK expression in osteoclast precursors. Medullary thymic epithelial cells and intestinal antigen-sampling microfold cells have been shown to express RANK. High expression of RANK was observed in some epithelial cells in the thymic medulla and intestine but not in osteoclast precursors in Fos(-/-) mice. RANK mRNA and protein levels in bone were lower in Fos(-/-) mice than RANKL(-/-) mice, suggesting that Fos-regulated RANK expression is tissue specific. When wild-type bone marrow cells were inoculated into Fos(-/-) mice, RANK-positive cells appeared along bones. RANK expression in wild-type macrophages was upregulated by coculturing with RANKL(-/-) osteoblasts as well as wild-type osteoblasts, suggesting that cytokines other than RANKL expressed by osteoblasts upregulate RANK expression in osteoclast precursors. CSF-1 receptor-positive cells were detected near CSF-1-expressing osteoblastic cells in bone in Fos(-/-) mice. CSF-1 upregulated RANK expression in wild-type macrophages but not Fos(-/-) macrophages. Overexpression of Fos in Fos(-/-) macrophages resulted in the upregulation of RANK expression. Overexpression of RANK in Fos(-/-) macrophages caused RANKL-induced signals, but failed to recover the RANKL-induced osteoclastogenesis. These results suggest that Fos plays essential roles in the upregulation of RANK expression in osteoclast precursors within the bone environment.

摘要

Fos 在由集落刺激因子 1(CSF-1)和核因子-κB 受体激活配体(RANKL;也称为肿瘤坏死因子配体超家族成员 11,Tnsf11)生成的前体细胞的破骨细胞分化中发挥重要作用。由于破骨细胞缺乏,RANKL 缺陷(RANKL(-/-))小鼠和 Fos(-/-) 小鼠表现出骨质增生。我们之前报道过,RANK 阳性的破骨细胞前体存在于 RANKL(-/-) 小鼠的骨骼中,但不存在于 Fos(-/-) 小鼠中。在这里,我们报告了 Fos 在破骨细胞前体中 RANK 表达中的作用。已经表明,骨髓胸腺上皮细胞和肠道抗原取样微褶细胞表达 RANK。在胸腺髓质和肠道的一些上皮细胞中观察到 RANK 的高表达,但在 Fos(-/-) 小鼠的破骨细胞前体中没有观察到。与 RANKL(-/-) 小鼠相比,Fos(-/-) 小鼠骨骼中的 RANK mRNA 和蛋白水平较低,这表明 Fos 调节的 RANK 表达是组织特异性的。当将野生型骨髓细胞接种到 Fos(-/-) 小鼠中时,RANK 阳性细胞出现在骨骼周围。与 RANKL(-/-) 成骨细胞以及野生型成骨细胞共培养可上调野生型巨噬细胞中的 RANK 表达,这表明成骨细胞表达的除 RANKL 以外的细胞因子可上调破骨细胞前体中的 RANK 表达。在 Fos(-/-) 小鼠的骨骼中,检测到 CSF-1 表达的成骨细胞附近存在 CSF-1 受体阳性细胞。CSF-1 上调野生型巨噬细胞中的 RANK 表达,但不影响 Fos(-/-) 巨噬细胞。在 Fos(-/-) 巨噬细胞中过表达 Fos 可上调 RANK 表达。在 Fos(-/-) 巨噬细胞中过表达 RANK 可导致 RANKL 诱导的信号,但未能恢复 RANKL 诱导的破骨细胞生成。这些结果表明,Fos 在骨骼环境中破骨细胞前体中 RANK 表达的上调中发挥重要作用。

相似文献

1
Fos plays an essential role in the upregulation of RANK expression in osteoclast precursors within the bone microenvironment.Fos 在骨微环境中破骨细胞前体的 RANK 表达上调中发挥重要作用。
J Cell Sci. 2012 Jun 15;125(Pt 12):2910-7. doi: 10.1242/jcs.099986. Epub 2012 Mar 27.
2
Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.核因子κB受体激活剂配体诱导破骨细胞前体RAW264.7细胞中碳酸酐酶II、组织蛋白酶K和基质金属蛋白酶-9的表达。
Life Sci. 2007 Mar 13;80(14):1311-8. doi: 10.1016/j.lfs.2006.12.037. Epub 2007 Jan 23.
3
Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.没食子儿茶素-3-没食子酸酯通过下调 c-Fos 表达和抑制核因子-κB 信号抑制破骨细胞生成。
Mol Pharmacol. 2010 Jan;77(1):17-25. doi: 10.1124/mol.109.057877. Epub 2009 Oct 14.
4
Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction.甲状腺激素通过一种独立于RANKL-RANK相互作用的机制刺激破骨细胞分化。
J Cell Physiol. 2004 Oct;201(1):17-25. doi: 10.1002/jcp.20041.
5
Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.曲匹地尔,一种血小板衍生生长因子拮抗剂,通过下调 NFATc1 抑制破骨细胞生成,并抑制小鼠的骨丢失。
Biochem Pharmacol. 2013 Sep 15;86(6):782-90. doi: 10.1016/j.bcp.2013.07.015. Epub 2013 Aug 6.
6
IL-1 plays an important role in the bone metabolism under physiological conditions.IL-1 在生理条件下的骨骼代谢中起着重要作用。
Int Immunol. 2010 Oct;22(10):805-16. doi: 10.1093/intimm/dxq431. Epub 2010 Aug 2.
7
The 4-1BB ligand and 4-1BB expressed on osteoclast precursors enhance RANKL-induced osteoclastogenesis via bi-directional signaling.破骨细胞前体上表达的4-1BB配体和4-1BB通过双向信号传导增强RANKL诱导的破骨细胞生成。
Eur J Immunol. 2008 Jun;38(6):1598-609. doi: 10.1002/eji.200737650.
8
Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL.曲古抑菌素 A 通过抑制 RANKL 诱导的 c-Fos 的表达来抑制破骨细胞的生成和骨吸收。
Eur J Pharmacol. 2009 Nov 25;623(1-3):22-9. doi: 10.1016/j.ejphar.2009.09.025. Epub 2009 Sep 17.
9
RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta.核因子κB受体活化因子配体(RANKL)通过依赖于c-Fos的干扰素-β诱导来维持骨稳态。
Nature. 2002 Apr 18;416(6882):744-9. doi: 10.1038/416744a.
10
Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells.白细胞介素-10部分通过抑制RAW264.7细胞和小鼠骨髓细胞中的c-Fos和c-Jun,来抑制RANKL介导的NFATc1表达。
Bone. 2007 Oct;41(4):592-602. doi: 10.1016/j.bone.2007.05.016. Epub 2007 Jun 13.

引用本文的文献

1
Systems genetics and bioinformatics analyses using ESR1-correlated genes identify potential candidates underlying female bone development.利用与 ESR1 相关的基因进行系统遗传学和生物信息学分析,确定女性骨骼发育的潜在候选基因。
Genomics. 2024 Jan;116(1):110769. doi: 10.1016/j.ygeno.2023.110769. Epub 2023 Dec 21.
2
Exploring the Anti-Osteoporotic Potential of Daucosterol: Impact on Osteoclast and Osteoblast Activities.探讨芝麻甾醇的抗骨质疏松潜力:对破骨细胞和成骨细胞活性的影响。
Int J Mol Sci. 2023 Nov 17;24(22):16465. doi: 10.3390/ijms242216465.
3
Osteoclast differentiation and dynamic mRNA expression during mice embryonic palatal bone development.
骨吸收细胞分化及小鼠胚胎腭骨发育过程中动态的 mRNA 表达。
Sci Rep. 2023 Sep 13;13(1):15170. doi: 10.1038/s41598-023-42423-4.
4
regulates osteoclastogenesis by inhibiting the c‑Fos/NFATc1 pathway and alleviating bone loss in an ovariectomy model.通过抑制 c-Fos/NFATc1 通路调节破骨细胞生成,并在卵巢切除模型中缓解骨质流失。
Mol Med Rep. 2023 Oct;28(4). doi: 10.3892/mmr.2023.13074. Epub 2023 Aug 18.
5
Extract Attenuates RANKL-Induced Osteoclastogenesis by Inhibiting the JNK/NF-κB/PLCγ2 Signaling Pathway.提取物通过抑制 JNK/NF-κB/PLCγ2 信号通路来抑制 RANKL 诱导的破骨细胞生成。
Nutrients. 2023 Jul 19;15(14):3193. doi: 10.3390/nu15143193.
6
Multiomic characterisation of the long-term sequelae of SARS survivors: a clinical observational study.SARS幸存者长期后遗症的多组学特征分析:一项临床观察性研究。
EClinicalMedicine. 2023 Apr;58:101884. doi: 10.1016/j.eclinm.2023.101884. Epub 2023 Feb 27.
7
A Vitronectin-Derived Peptide Restores Ovariectomy-Induced Bone Loss by Dual Regulation of Bone Remodeling.一种来源于纤连蛋白的肽通过双重调节骨重塑来恢复去卵巢引起的骨丢失。
Tissue Eng Regen Med. 2022 Dec;19(6):1359-1376. doi: 10.1007/s13770-022-00486-w. Epub 2022 Oct 7.
8
A Review of Signaling Transduction Mechanisms in Osteoclastogenesis Regulation by Autophagy, Inflammation, and Immunity.自噬、炎症与免疫调控破骨细胞分化的信号转导机制研究进展
Int J Mol Sci. 2022 Aug 30;23(17):9846. doi: 10.3390/ijms23179846.
9
Osteoclast biology in the single-cell era.单细胞时代的破骨细胞生物学
Inflamm Regen. 2022 Sep 2;42(1):27. doi: 10.1186/s41232-022-00213-x.
10
Effects of on Osteoclast Formation and Osteoblast Differentiation and on an OVX-Induced Bone Loss Model.对破骨细胞形成和成骨细胞分化以及对去卵巢诱导的骨丢失模型的影响。
Front Pharmacol. 2022 Jan 4;12:797892. doi: 10.3389/fphar.2021.797892. eCollection 2021.